Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis

In people with idiopathic pulmonary fibrosis, circulating fibrocytes ≥2.2% were associated with a greater risk of mortality over a median 3 years of follow-up, but were not associated with disease-related decline in lung function or short-term progression. https://bit.ly/3bWydwQ

Detalles Bibliográficos
Autores principales: Stewart, Iain D., Nanji, Henry, Figueredo, Grazziela, Fahy, William A., Maher, Toby M., Ask, Antje J., Maharaj, Shyam, Ask, Kjetil, Kolb, Martin, Jenkins, Gisli R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295504/
https://www.ncbi.nlm.nih.gov/pubmed/33766945
http://dx.doi.org/10.1183/13993003.00172-2021
_version_ 1783725442978545664
author Stewart, Iain D.
Nanji, Henry
Figueredo, Grazziela
Fahy, William A.
Maher, Toby M.
Ask, Antje J.
Maharaj, Shyam
Ask, Kjetil
Kolb, Martin
Jenkins, Gisli R.
author_facet Stewart, Iain D.
Nanji, Henry
Figueredo, Grazziela
Fahy, William A.
Maher, Toby M.
Ask, Antje J.
Maharaj, Shyam
Ask, Kjetil
Kolb, Martin
Jenkins, Gisli R.
author_sort Stewart, Iain D.
collection PubMed
description In people with idiopathic pulmonary fibrosis, circulating fibrocytes ≥2.2% were associated with a greater risk of mortality over a median 3 years of follow-up, but were not associated with disease-related decline in lung function or short-term progression. https://bit.ly/3bWydwQ
format Online
Article
Text
id pubmed-8295504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-82955042021-07-22 Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis Stewart, Iain D. Nanji, Henry Figueredo, Grazziela Fahy, William A. Maher, Toby M. Ask, Antje J. Maharaj, Shyam Ask, Kjetil Kolb, Martin Jenkins, Gisli R. Eur Respir J Agora In people with idiopathic pulmonary fibrosis, circulating fibrocytes ≥2.2% were associated with a greater risk of mortality over a median 3 years of follow-up, but were not associated with disease-related decline in lung function or short-term progression. https://bit.ly/3bWydwQ European Respiratory Society 2021-07-22 /pmc/articles/PMC8295504/ /pubmed/33766945 http://dx.doi.org/10.1183/13993003.00172-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by/4.0/This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
spellingShingle Agora
Stewart, Iain D.
Nanji, Henry
Figueredo, Grazziela
Fahy, William A.
Maher, Toby M.
Ask, Antje J.
Maharaj, Shyam
Ask, Kjetil
Kolb, Martin
Jenkins, Gisli R.
Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title_full Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title_fullStr Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title_full_unstemmed Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title_short Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
title_sort circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295504/
https://www.ncbi.nlm.nih.gov/pubmed/33766945
http://dx.doi.org/10.1183/13993003.00172-2021
work_keys_str_mv AT stewartiaind circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT nanjihenry circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT figueredograzziela circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT fahywilliama circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT mahertobym circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT askantjej circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT maharajshyam circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT askkjetil circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT kolbmartin circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis
AT jenkinsgislir circulatingfibrocytesarenotdiseasespecificprognosticatorsinidiopathicpulmonaryfibrosis

Ejemplares similares